Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4096632 | 0.93 | TSHR (0.46) | ALDH1A1TSHRTHRB | |
| SCHEMBL137981 | 0.91 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRB | |
| SCHEMBL13126153 | 0.91 | TSHR (0.45) | ALDH1A1TSHRTHRB | |
| SCHEMBL8494461 | 0.87 | TSHR (0.42) | ALDH1A1TSHRTHRB | |
| SCHEMBL10350826 | 0.87 | TSHR (0.42) | ALDH1A1TSHRTHRB | |
| SCHEMBL2696368 | 0.86 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL10350827 | 0.85 | TSHR (0.41) | ALDH1A1TSHRTHRB | |
| Methacrylic Acid SCHEMBL28142674 | 0.85 | ALDH1A1 (0.44) | ALDH1A1TSHRTHRB | |
| SCHEMBL7634557 | 0.85 | TSHR (0.41) | ALDH1A1TSHRTHRB | |
| SCHEMBL27620036 | 0.85 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1061 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687925-A1 | THYMIC CELL COMPOSITIONS AND METHODS OF MAKING | Thymmune Therapeutics, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-12-25 | — | — | US | claimed |
| US-20250298042-A1 | ENGINEERED PARTICLES AS RED BLOOD CELL MIMICS AND COMPOSITIONS CONTAINING SAME FOR HEMATOLOGY | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-09-25 | — | — | US | claimed |
| EP-4608872-A2 | SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION | Slingshot Biosciences, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-12379387-B2 | Engineered particles as red blood cell mimics and compositions containing same for hematology | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-08-05 | — | — | US | claimed |
| EP-3256850-B1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES INC (US) | 2025-07-09 | — | — | EP | claimed |
| US-12352679-B2 | Synthetic human cell mimic particle for cytometric or coulter device | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-07-08 | — | — | US | claimed |
| EP-4577823-A2 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | Slingshot Biosciences, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| US-20250189428-A1 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-06-12 | — | — | US | claimed |
| US-12312595-B2 | Hydrogel particles as feeder cells and as synthetic antigen presenting cells | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-05-27 | — | — | US | claimed |
| EP-0626977-B1 | ABC TRIBLOCK METHACRYLATE POLYMERS | DU PONT (US) | 1997-07-09 | — | — | EP | claimed |
| WO-1996025923-A1 | A PROCESS FOR THE PREPARATION OF AN EMULSION NETWORK FOR A TRANSDERMAL DRUG DELIVERY SYSTEM | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1996-08-29 | — | — | WO | claimed |
| EP-0719135-A1 | TRANSDERMAL DRUG DELIVERY SYSTEM HAVING IONIC POLYMER NETWORKS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1996-07-03 | — | — | EP | claimed |
| WO-1995030411-A1 | TRANSDERMAL DRUG DELIVERY SYSTEM HAVING IONIC POLYMER NETWORKS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1995-11-16 | — | — | WO | claimed |
| EP-0626977-A1 | ABC TRIBLOCK METHACRYLATE POLYMERS. | DU PONT (US) | 1994-12-07 | — | — | EP | claimed |
| WO-1993017057-A1 | ABC TRIBLOCK METHACRYLATE POLYMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-02 | — | — | WO | claimed |
| US-5219945-A | Having each block different, at least one hydrophilic and one hydrophobic | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-06-15 | — | — | US | claimed |
| US-5098696-A | Methacrylate monomers for polymers with tert-amine promoters and di or trimethacrylate monomers and peroxide catalysts | REM SYSTEMS, INC. (US) | 1992-03-24 | — | — | US | claimed |
| US-4871534-A | METHACRYLATE BINDER, METHACRYLATE POLYMER, PEROXIDE INITIATOR | REM SYSTEMS, INC. (US) | 1989-10-03 | — | — | US | claimed |
| EP-0080680-A2 | Reference electrode catheter | Sentron v.o.f. (NL) | 1983-06-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | CD4, ICOS, CD69 | ALDH1A1 3752/4885TSHR 225/4885THRB 502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.